Article: Court Confirms PharmaNetics' Allegation That Aventis Has Engaged in False Advertising of Lovenox; PharmaNetics Entitled to Jury Trial.

Business Editors/Health/Medical Writers

RALEIGH, N.C.--(BUSINESS WIRE)--May 4, 2004

PharmaNetics, Inc. (NASDAQ-SmallCap: PHAR) today announced that it has received a ruling from the United States District Court of the Eastern District of North Carolina.

In November 2003, PharmaNetics, Inc. filed a lawsuit in the United States District Court of the Eastern District of North Carolina against Aventis Pharmaceuticals, Inc., the wholly owned subsidiary of French pharmaceutical company, Aventis. The lawsuit alleges that Aventis has engaged in false and misleading advertising of its second largest drug, Lovenox(R). In addition to claims of false ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!